MedPath

Effect of Probiotic Intake on Improvement of Higher Cerebral Function in Participants with Suspected Mild Cognitive Impairment

Not Applicable
Conditions
Healthy subjects
Registration Number
JPRN-UMIN000037725
Lead Sponsor
HUMA R&D CORP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subject who is diagnosed as dementia. 2)Subject who is under exercise therapy or dietetic therapy. 3)Subject who has an allergy for test food. 4)Subject who has or had a history of either medicine or alcohol dependence syndrome. 5)Subject who has or had a history of mental illness (depression) or sleep disturbance. 6)Subject who is on a night-shift or is a shift worker. 7)Subject whose lifestyle is extremely irregular. 8)Subject who has an unbalanced diet. 9)ubjects who have disease or history of diabetes, liver disease(hepatitis), kidney disease, heart disease, thyroid disease, adrenal disease, and metabolic disease. 10)Subject who uses health foods, supplements, and medicines that may affect cognitive function 11)Subjects who has undergone surgery of the gastrointestinal tract(Appendicitis is excluded). 12)Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13)Subject who has blood drawn 200mL within the past 1 months or 400mL within the past 3 months from the day of the consent acquisition. 14Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating. 15)Subject who can't keep the daily records. 16)Subject who is judged as an inappropriate candidate according to the screening data. 17)Subject who is considered as an inappropriate candidate by the doctor in charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath